Professor of Biomedical Engineering, Johns Hopkins University
I did the first experiments showing altered DNA methylation in cancer. I showed that epigenetic changes (chemical changes other than DNA sequence per se) cause cancer are not simply consequential to it through my studies of the disorder Beckwith-Wiedemann syndrome. Later I had the first NIH funded epigenome center. More recently I have developed the idea the genetic variants can control epigenetic stochasticity (plasticity) and phenotype (traits) under evolutionary selection in natural populations, or within an individual in the development of cancer.
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight